EX-FILING FEES 4 d293656dexfilingfees.htm EX-FILING FEES EX-FILING FEES

Exhibit 107.1

Calculation of Filing Fee Table

Form S-3

(Form Type)

ALX Oncology Holdings Inc.

(Exact name of registrant as specified in its charter)

Table 1 – Newly Registered and Carry Forward Securities

 

     Security
Type
  Security Class Title   Fee
Calculation
or Carry
Forward
Rule
  Amount
Registered
  Proposed
Maximum
Offering
Price Per
Unit
  Maximum
Aggregate
Offering Price
  Fee Rate   Amount of
Registration
Fee
  Carry
Forward
Form
Type
 

Carry

Forward

File

Number

 

Carry

Forward

Initial

Effective

Date

  Filing Fee
Previously
Paid In
Connection
with Unsold
Securities to
be Carried
Forward
Newly Registered Securities
Fees to Be Paid   Equity   Common Stock, $0.001 par value per share   Rule 457(o)   (1)   (2)   (2)                        
  Equity   Preferred Stock, $0.001 par value per share   Rule 457(o)   (1)   (2)   (2)                        
  Other   Warrants   Rule 457(o)   (1)   (2)   (2)                        
  Other   Purchase Contracts   Rule 457(o)   (1)   (2)   (2)                        
  Other   Units(4)   Rule 457(o)   (1)   (2)   (2)                        
  Other   N/A   Rule 457(o)   N/A   N/A   $450,000,000   0.0000927   $41,715                

Fees Previously 

Paid

  N/A   N/A   N/A   N/A   N/A   N/A       N/A                
Carry Forward Securities
Carry Forward Securities   —     Common Stock, par value $0.001 per share  

Rule 457(o)

Rule 457(p)

  N/A   N/A   $150,000,000 (4)   0.0000927   N/A   424B5   333-258812   December 17, 2021   $13,905
    Total Offering Amounts        $450,000,000   0.0000927   $41,715                
    Total Fees Previously Paid                $0                
    Total Fee Offsets                $13,905                
    Net Fee Due                $27,810                

 

(1)

An indeterminate aggregate initial offering price or number of the securities of each identified class is being registered as may from time to time be issued at indeterminate prices. Separate consideration may not be received for registered securities that are issuable upon the exercise, conversion or exchange of other securities. Pursuant to Rule 416 under the Securities Act of 1933, as amended, or the Securities Act, the shares being registered hereunder include such indeterminate number of shares of common stock and preferred stock as may be issuable with respect to the shares being registered hereunder as a result of stock splits, stock dividends or similar transactions. The aggregate maximum offering price of all securities issued under this Registration Statement will not exceed $450,000,000.

 

(2)

The proposed maximum per security and aggregate offering prices per class of securities will be determined from time to time by the registrant in connection with the issuance by the registrant of the securities registered hereunder and is not specified as to each class of security pursuant to General Instruction II.D. of Form S-3 under the Securities Act. Separate consideration may or may not be received for securities that are issuable on exercise, conversion or exchange of other securities, or that are issued in units.

 

(3)

Consisting of some or all of the securities listed above, in any combination, including common stock, preferred stock, warrants and purchase contracts.

 

(4)

Pursuant Rule 457(p) under the Securities Act, the Registrant hereby offsets $13,905 of the total registration fee due under this Registration Statement by the amount of the filing fee associated with the unsold securities from the Registrant’s Prospectus Supplement to its prior Registration Statement (File No. 333-258812), filed on December 17, 2021 registering common stock for a maximum aggregate offering price of $150,000,000, the entire amount of which remains unsold as of the filing date of this Registration Statement. Pursuant to Rule 457(p), the associated filing fee of $13,905 is hereby used to offset the current registration fee due. As a result, a filing fee of $27,810 is being paid herewith.